Swiss medical technology enterprise Scanvio Medical has developed an AI-assisted gynecological ultrasound diagnosis software to improve the diagnostic efficiency of endometriosis | Top 100 Swiss Innovations
Image source: Scanvio Medical
Swiss medical technology company Scanvio Medical was founded in 2024, dedicated to the research and development of AI-assisted gynecological ultrasound diagnostic software. The software can perform real-time analysis on dynamic transvaginal ultrasound images, helping doctors detect, locate and judge lesions related to endometriosis, and improve the consistency of examination standards and diagnostic efficiency.
Scanvio Medical is a spin-off company of ETH Zurich, co-founded by Stefan Tuchschmid and Fabian Laumer, among others. Stefan Tuchschmid, CEO of the company, holds a doctorate in engineering science from ETH Zurich, with main research direction of high-fidelity surgical simulation system for hysteroscopy, and has participated in the founding of medical simulation company VirtaMed. Fabian Laumer, Chief Technology Officer of the company, holds a doctorate in machine learning from ETH Zurich, whose research focuses on the use of deep learning to analyze ultrasound images and ultrasound videos, including the reconstruction of three-dimensional cardiac structures based on echocardiography and other directions.
Image source
Endometriosis affects about 10% of women of childbearing age, and patients often suffer from severe dysmenorrhea, menorrhagia, chronic pelvic pain and infertility. Since lesions can be distributed in multiple pelvic sites such as ovaries, around the uterus, intestines, and bladder, and the size, shape and severity of lesions vary greatly among different patients, the disease is highly difficult to identify and confirm. At present, clinical diagnosis mainly relies on laparoscopy and professional ultrasound examination. Laparoscopy can directly observe and sample lesions, but it is an invasive examination with anesthesia risks, surgical risks and high costs, so it is not suitable as a routine screening method; ultrasound examination is highly dependent on doctor experience and professional ultrasound resources, and there is still a risk of missed diagnosis for small, hidden or atypical lesions. In addition, there are differences among different doctors in scanning procedures, lesion judgment and report recording, which further affects the consistency and standardization of diagnostic results. Affected by the above factors, it often takes years for patients from the onset of symptoms to a clear diagnosis, and some studies show that the diagnostic delay can reach 8-12 years.
Image source: Scanvio Medical
Scanvio Medical has developed AI-assisted gynecological ultrasound diagnostic software, which can assist clinicians in diagnosing endometriosis during routine pelvic ultrasound examinations, replacing invasive laparoscopy with non-invasive AI-assisted ultrasound examinations to achieve accurate, non-invasive and convenient diagnosis of endometriosis.
Trained on expert data, the software can be connected to existing ultrasound devices as an information overlay during ultrasound examinations, continuously reading and analyzing dynamic ultrasound videos during doctors' examinations, automatically identifying and marking pelvic anatomical structures such as uterus, ovaries and intestines, and combining the positional relationship of organs, mobility and abnormal tissue features to assist in the detection of suspected abnormal manifestations such as endometriotic nodules, organ adhesions and deep infiltration. Compared with analyzing only a single static ultrasound image, the software can continuously understand real-time ultrasound videos and doctors' operation processes, helping doctors to cover relevant anatomical areas more systematically during examinations, and reducing the omission of lesions caused by differences in operational experience. At the same time, the system can also assist doctors in judging the lesion location, involved organs, distribution scope and disease severity, and make structured and standardized records of relevant findings, providing a basis for subsequent patient referral, disease grading, treatment decision-making and surgical planning. The software is currently undergoing CE certification conformity assessment in accordance with the EU Medical Device Regulation MDR and has not yet entered large-scale commercial sales.
At present, Scanvio Medical has carried out cooperation with clinical institutions including the Endometriosis Center of University Hospital of Zurich, and opened product reservations through the official website at the same time to promote trial and feedback collection for potential hospital customers and clinicians. In addition, the company plans to cooperate with ultrasound equipment manufacturers for integration to achieve large-scale deployment, and prepare for international market expansion.
In July 2025, Scanvio Medical completed a $3.4 million seed round of financing, with investors including StartAngels, superangels and Stöckli Medical, etc. The funds are mainly used to accelerate the R&D of AI ultrasound diagnostic technology, expand clinical cooperation, and promote CE and FDA regulatory approvals.
Scanvio Medical was listed in the TOP100 Swiss Startups 2025. The TOP100 Swiss Startups brings together the best "Swiss Made" technology innovation enterprises in the startup and growth stages, and is the most internationally influential benchmark list in Switzerland's technology innovation field. Since 2011, the list has selected 100 of the most pioneering and market-prospective Swiss innovative enterprises and 25 Swiss growth enterprises with the most unicorn potential across Switzerland every year, covering fields such as life sciences, engineering machinery, robotics, information and communication, low-carbon technology, and food technology. The TOP100 Swiss Startups and its series of brand events are landmark activities in Switzerland's innovation ecosystem, representing the highest ground of Swiss innovation and the forefront of international investment and financing.
The Chinese version of TOP100 Swiss Startups 2025 is honorably released by Insight Tech. Insight Tech is the authorized Chinese partner of TOP100 Swiss Startups, responsible for the operation and promotion of TOP100 Swiss Startups in China and assisting the list projects in China-related commercial cooperation. As a service provider for Sino-European (Swiss) industrial innovation cooperation, Insight Tech is committed to promoting the sinicization of Swiss innovation and the internationalization of Chinese industries through ecological construction and cross-border empowerment.
To obtain the full list and industry-specific lists of TOP100 Swiss Startups, please visit the official WeChat account or official website of Insight Tech.